Selected research
Market Analysis & Forecast
Global Pharmaceutical and Medical Device Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Pharmaceutical and Medical Device Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pharmaceutical and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pharmaceutical and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pharmaceutical and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pharmaceutical and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pharmaceutical and Medical Device Testing include SGS, Shimadzu, Charles River Laboratories, Eurofins, RCTS, Nelson Laboratories, DeviceLab, EAG Laboratories and EdgeOne Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical and Medical Device Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharmaceutical and Medical Device Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical and Medical Device Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical and Medical Device Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical and Medical Device Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical and Medical Device Testing revenue, projected growth trends, production technology, application and end-user industry.
Pharmaceutical and Medical Device Testing Segment by Company
SGS
Shimadzu
Charles River Laboratories
Eurofins
RCTS
Nelson Laboratories
DeviceLab
EAG Laboratories
EdgeOne Medical
Element
NAMSA
Pace Labs
Intertek
Associates of Cape Cod (ACC)
Tentamus
EKG Labs
MycoScience
GDMDT
Guangdong Lewwin
GTTC
PONY
Guangzhou Guobiao
CAS Testing Technical Services
Guangzhou General Pharmaceutical Research Institute
Guangdong Huawei Testing
Shanghai Ingeer
CIRS
Shanghai Fuda
Pharmaceutical and Medical Device Testing Segment by Type
Drug Testing
Medical Device Testing
Pharmaceutical and Medical Device Testing Segment by Application
Enterprise
Research Institution
College and University
Pharmaceutical and Medical Device Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Medical Device Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmaceutical and Medical Device Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmaceutical and Medical Device Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical and Medical Device Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Pharmaceutical and Medical Device Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. Drug Testing Major Player
Table 3. Medical Device Testing Major Player
Table 4. Global Pharmaceutical and Medical Device Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 5. Enterprise Major Player
Table 6. Research Institution Major Player
Table 7. College and University Major Player
Table 8. Pharmaceutical and Medical Device Testing Industry Trends
Table 9. Pharmaceutical and Medical Device Testing Industry Drivers
Table 10. Pharmaceutical and Medical Device Testing Industry Opportunities and Challenges
Table 11. Pharmaceutical and Medical Device Testing Industry Restraints
Table 12. Global Pharmaceutical and Medical Device Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 13. Global Pharmaceutical and Medical Device Testing Market Size by Region (2021-2026) & (US$ Million)
Table 14. Global Pharmaceutical and Medical Device Testing Market Share by Region (2021-2026)
Table 15. Global Pharmaceutical and Medical Device Testing Market Size by Region (2027-2032) & (US$ Million)
Table 16. Global Pharmaceutical and Medical Device Testing Market Share by Region (2027-2032)
Table 17. Global Pharmaceutical and Medical Device Testing Revenue by Players (US$ Million) & (2021-2026)
Table 18. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Players (2021-2026)
Table 19. Global Pharmaceutical and Medical Device Testing Key Players Ranking, 2024 VS 2025 VS 2026
Table 20. Global Pharmaceutical and Medical Device Testing Key Players Headquarters & Area Served
Table 21. Global Pharmaceutical and Medical Device Testing Players, Product Type & Application
Table 22. Global Pharmaceutical and Medical Device Testing Players Establishment Date
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Pharmaceutical and Medical Device Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 25. Global Pharmaceutical and Medical Device Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 27. Global Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 28. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Type (2027-2032)
Table 30. Global Pharmaceutical and Medical Device Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 32. Global Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 33. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Application (2021-2026)
Table 34. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Application (2027-2032)
Table 35. SGS Company Information
Table 36. SGS Business Overview
Table 37. SGS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 38. SGS Pharmaceutical and Medical Device Testing Product Portfolio
Table 39. SGS Recent Development
Table 40. Shimadzu Company Information
Table 41. Shimadzu Business Overview
Table 42. Shimadzu Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 43. Shimadzu Pharmaceutical and Medical Device Testing Product Portfolio
Table 44. Shimadzu Recent Development
Table 45. Charles River Laboratories Company Information
Table 46. Charles River Laboratories Business Overview
Table 47. Charles River Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 48. Charles River Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 49. Charles River Laboratories Recent Development
Table 50. Eurofins Company Information
Table 51. Eurofins Business Overview
Table 52. Eurofins Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 53. Eurofins Pharmaceutical and Medical Device Testing Product Portfolio
Table 54. Eurofins Recent Development
Table 55. RCTS Company Information
Table 56. RCTS Business Overview
Table 57. RCTS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 58. RCTS Pharmaceutical and Medical Device Testing Product Portfolio
Table 59. RCTS Recent Development
Table 60. Nelson Laboratories Company Information
Table 61. Nelson Laboratories Business Overview
Table 62. Nelson Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 63. Nelson Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 64. Nelson Laboratories Recent Development
Table 65. DeviceLab Company Information
Table 66. DeviceLab Business Overview
Table 67. DeviceLab Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 68. DeviceLab Pharmaceutical and Medical Device Testing Product Portfolio
Table 69. DeviceLab Recent Development
Table 70. EAG Laboratories Company Information
Table 71. EAG Laboratories Business Overview
Table 72. EAG Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 73. EAG Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 74. EAG Laboratories Recent Development
Table 75. EdgeOne Medical Company Information
Table 76. EdgeOne Medical Business Overview
Table 77. EdgeOne Medical Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 78. EdgeOne Medical Pharmaceutical and Medical Device Testing Product Portfolio
Table 79. EdgeOne Medical Recent Development
Table 80. Element Company Information
Table 81. Element Business Overview
Table 82. Element Pharmaceutical and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 83. Element Pharmaceutical and Medical Device Testing Product Portfolio
Table 84. Element Recent Development
Table 85. NAMSA Company Information
Table 86. NAMSA Business Overview
Table 87. NAMSA Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 88. NAMSA Pharmaceutical and Medical Device Testing Product Portfolio
Table 89. NAMSA Recent Development
Table 90. Pace Labs Company Information
Table 91. Pace Labs Business Overview
Table 92. Pace Labs Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 93. Pace Labs Pharmaceutical and Medical Device Testing Product Portfolio
Table 94. Pace Labs Recent Development
Table 95. Intertek Company Information
Table 96. Intertek Business Overview
Table 97. Intertek Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. Intertek Pharmaceutical and Medical Device Testing Product Portfolio
Table 99. Intertek Recent Development
Table 100. Associates of Cape Cod (ACC) Company Information
Table 101. Associates of Cape Cod (ACC) Business Overview
Table 102. Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Product Portfolio
Table 104. Associates of Cape Cod (ACC) Recent Development
Table 105. Tentamus Company Information
Table 106. Tentamus Business Overview
Table 107. Tentamus Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 108. Tentamus Pharmaceutical and Medical Device Testing Product Portfolio
Table 109. Tentamus Recent Development
Table 110. EKG Labs Company Information
Table 111. EKG Labs Business Overview
Table 112. EKG Labs Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 113. EKG Labs Pharmaceutical and Medical Device Testing Product Portfolio
Table 114. EKG Labs Recent Development
Table 115. MycoScience Company Information
Table 116. MycoScience Business Overview
Table 117. MycoScience Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 118. MycoScience Pharmaceutical and Medical Device Testing Product Portfolio
Table 119. MycoScience Recent Development
Table 120. GDMDT Company Information
Table 121. GDMDT Business Overview
Table 122. GDMDT Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 123. GDMDT Pharmaceutical and Medical Device Testing Product Portfolio
Table 124. GDMDT Recent Development
Table 125. Guangdong Lewwin Company Information
Table 126. Guangdong Lewwin Business Overview
Table 127. Guangdong Lewwin Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 128. Guangdong Lewwin Pharmaceutical and Medical Device Testing Product Portfolio
Table 129. Guangdong Lewwin Recent Development
Table 130. GTTC Company Information
Table 131. GTTC Business Overview
Table 132. GTTC Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 133. GTTC Pharmaceutical and Medical Device Testing Product Portfolio
Table 134. GTTC Recent Development
Table 135. PONY Company Information
Table 136. PONY Business Overview
Table 137. PONY Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 138. PONY Pharmaceutical and Medical Device Testing Product Portfolio
Table 139. PONY Recent Development
Table 140. Guangzhou Guobiao Company Information
Table 141. Guangzhou Guobiao Business Overview
Table 142. Guangzhou Guobiao Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 143. Guangzhou Guobiao Pharmaceutical and Medical Device Testing Product Portfolio
Table 144. Guangzhou Guobiao Recent Development
Table 145. CAS Testing Technical Services Company Information
Table 146. CAS Testing Technical Services Business Overview
Table 147. CAS Testing Technical Services Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 148. CAS Testing Technical Services Pharmaceutical and Medical Device Testing Product Portfolio
Table 149. CAS Testing Technical Services Recent Development
Table 150. Guangzhou General Pharmaceutical Research Institute Company Information
Table 151. Guangzhou General Pharmaceutical Research Institute Business Overview
Table 152. Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 153. Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Product Portfolio
Table 154. Guangzhou General Pharmaceutical Research Institute Recent Development
Table 155. Guangdong Huawei Testing Company Information
Table 156. Guangdong Huawei Testing Business Overview
Table 157. Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 158. Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Product Portfolio
Table 159. Guangdong Huawei Testing Recent Development
Table 160. Shanghai Ingeer Company Information
Table 161. Shanghai Ingeer Business Overview
Table 162. Shanghai Ingeer Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 163. Shanghai Ingeer Pharmaceutical and Medical Device Testing Product Portfolio
Table 164. Shanghai Ingeer Recent Development
Table 165. CIRS Company Information
Table 166. CIRS Business Overview
Table 167. CIRS Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 168. CIRS Pharmaceutical and Medical Device Testing Product Portfolio
Table 169. CIRS Recent Development
Table 170. Shanghai Fuda Company Information
Table 171. Shanghai Fuda Business Overview
Table 172. Shanghai Fuda Pharmaceutical and Medical Device Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 173. Shanghai Fuda Pharmaceutical and Medical Device Testing Product Portfolio
Table 174. Shanghai Fuda Recent Development
Table 175. North America Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 176. North America Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 177. North America Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 178. North America Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 179. North America Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 180. North America Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million)
Table 181. North America Pharmaceutical and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032)
Table 182. Europe Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 183. Europe Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 184. Europe Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 185. Europe Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 186. Europe Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 187. Europe Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million)
Table 188. Europe Pharmaceutical and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032)
Table 189. China Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 190. China Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 191. China Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 192. China Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 193. Asia Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 194. Asia Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 195. Asia Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 196. Asia Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 197. Asia Pharmaceutical and Medical Device Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
Table 198. Asia Pharmaceutical and Medical Device Testing Revenue by Region (US$ Million) & (2021-2026)
Table 199. Asia Pharmaceutical and Medical Device Testing Revenue by Region (US$ Million) & (2027-2032)
Table 200. SAMEA Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million)
Table 201. SAMEA Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million)
Table 202. SAMEA Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million)
Table 203. SAMEA Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million)
Table 204. SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 205. SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million)
Table 206. SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032)
Table 207. Research Programs/Design for This Report
Table 208. Authors List of This Report
Table 209. Secondary Sources
Table 210. Primary Sources
List of Figures
Figure 1. Pharmaceutical and Medical Device Testing Image
Figure 2. Global Pharmaceutical and Medical Device Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Pharmaceutical and Medical Device Testing Market Size Share 2021 VS 2025 VS 2032
Figure 4. Drug Testing Image
Figure 5. Medical Device Testing Image
Figure 6. Global Pharmaceutical and Medical Device Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 7. Global Pharmaceutical and Medical Device Testing Market Size Share 2021 VS 2025 VS 2032
Figure 8. Enterprise Image
Figure 9. Research Institution Image
Figure 10. College and University Image
Figure 11. Global Pharmaceutical and Medical Device Testing Market Size (US$ Million) & (2021-2032)
Figure 12. Global Pharmaceutical and Medical Device Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 13. Global Pharmaceutical and Medical Device Testing Market Share by Region: 2021 VS 2025 VS 2032
Figure 14. Global Pharmaceutical and Medical Device Testing Players Revenue Share Top 10 and Top 5 in 2025
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 16. Global Pharmaceutical and Medical Device Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Pharmaceutical and Medical Device Testing Revenue Market Share 2021 VS 2025 VS 2032
Figure 18. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Type (2021-2032)
Figure 19. Global Pharmaceutical and Medical Device Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Application (2021 VS 2025 VS 2032)
Figure 21. Global Pharmaceutical and Medical Device Testing Revenue Market Share by Application (2021-2032)
Figure 22. North America Pharmaceutical and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
Figure 24. North America Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
Figure 25. North America Pharmaceutical and Medical Device Testing Revenue Share by Country (2021-2032)
Figure 26. United States Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 27. Canada Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 28. Mexico Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 29. Europe Pharmaceutical and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
Figure 31. Europe Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
Figure 32. Europe Pharmaceutical and Medical Device Testing Revenue Share by Country (2021-2032)
Figure 33. Germany Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 34. France Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 35. U.K. Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 36. Italy Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 37. Spain Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 38. Russia Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 39. Netherlands Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 40. Nordic Countries Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 41. China Pharmaceutical and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 42. China Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
Figure 43. China Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
Figure 44. Asia Pharmaceutical and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 45. Asia Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
Figure 46. Asia Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
Figure 47. Asia Pharmaceutical and Medical Device Testing Revenue Share by Region (2021-2032)
Figure 48. Japan Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 49. South Korea Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 50. India Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 51. Australia Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 52. Taiwan Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 53. Southeast Asia Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 54. SAMEA Pharmaceutical and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 55. SAMEA Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
Figure 56. SAMEA Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
Figure 57. SAMEA Pharmaceutical and Medical Device Testing Revenue Share by Country (2021-2032)
Figure 58. Brazil Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 59. Argentina Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 60. Chile Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 61. Colombia Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 62. Peru Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 63. Saudi Arabia Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 64. Israel Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 65. UAE Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 66. Turkey Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 67. Iran Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 68. Egypt Pharmaceutical and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 69. Years Considered
Figure 70. Research Process
Figure 71. Key Executives Interviewed
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Enterprise
- Research Institution
- College and University
Companies covered
- SGS
- Shimadzu
- Charles River Laboratories
- Eurofins
- RCTS
- Nelson Laboratories
- DeviceLab
- EAG Laboratories
- EdgeOne Medical
- Element
- NAMSA
- Pace Labs
- Intertek
- Associates of Cape Cod (ACC)
- Tentamus
- EKG Labs
- MycoScience
- GDMDT
- Guangdong Lewwin
- GTTC
- PONY
- Guangzhou Guobiao
- CAS Testing Technical Services
- Guangzhou General Pharmaceutical Research Institute
- Guangdong Huawei Testing
- Shanghai Ingeer
- CIRS
- Shanghai Fuda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharmaceutical and Medical Device Testing Market by Type
- 1.2.1 Global Pharmaceutical and Medical Device Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Drug Testing
- 1.2.3 Medical Device Testing
- 1.3 Pharmaceutical and Medical Device Testing Market by Application
- 1.3.1 Global Pharmaceutical and Medical Device Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Enterprise
- 1.3.3 Research Institution
- 1.3.4 College and University
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical and Medical Device Testing Market Dynamics
- 2.1 Pharmaceutical and Medical Device Testing Industry Trends
- 2.2 Pharmaceutical and Medical Device Testing Industry Drivers
- 2.3 Pharmaceutical and Medical Device Testing Industry Opportunities and Challenges
- 2.4 Pharmaceutical and Medical Device Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pharmaceutical and Medical Device Testing Market Perspective (2021-2032)
- 3.2 Global Pharmaceutical and Medical Device Testing Growth Trends by Region
- 3.2.1 Global Pharmaceutical and Medical Device Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharmaceutical and Medical Device Testing Market Size by Region (2021-2026)
- 3.2.3 Global Pharmaceutical and Medical Device Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pharmaceutical and Medical Device Testing Revenue by Players
- 4.1.1 Global Pharmaceutical and Medical Device Testing Revenue by Players (2021-2026)
- 4.1.2 Global Pharmaceutical and Medical Device Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pharmaceutical and Medical Device Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharmaceutical and Medical Device Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pharmaceutical and Medical Device Testing Key Players Headquarters & Area Served
- 4.4 Global Pharmaceutical and Medical Device Testing Players, Product Type & Application
- 4.5 Global Pharmaceutical and Medical Device Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pharmaceutical and Medical Device Testing Market CR5 and HHI
- 4.6.3 2025 Pharmaceutical and Medical Device Testing Tier 1, Tier 2, and Tier 3
5 Pharmaceutical and Medical Device Testing Market Size by Type
- 5.1 Global Pharmaceutical and Medical Device Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 5.3 Global Pharmaceutical and Medical Device Testing Revenue Market Share by Type (2021-2032)
6 Pharmaceutical and Medical Device Testing Market Size by Application
- 6.1 Global Pharmaceutical and Medical Device Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 6.3 Global Pharmaceutical and Medical Device Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Pharmaceutical and Medical Device Testing Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 Shimadzu
- 7.2.1 Shimadzu Company Information
- 7.2.2 Shimadzu Business Overview
- 7.2.3 Shimadzu Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Shimadzu Pharmaceutical and Medical Device Testing Product Portfolio
- 7.2.5 Shimadzu Recent Developments
- 7.3 Charles River Laboratories
- 7.3.1 Charles River Laboratories Company Information
- 7.3.2 Charles River Laboratories Business Overview
- 7.3.3 Charles River Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 Charles River Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 7.3.5 Charles River Laboratories Recent Developments
- 7.4 Eurofins
- 7.4.1 Eurofins Company Information
- 7.4.2 Eurofins Business Overview
- 7.4.3 Eurofins Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Eurofins Pharmaceutical and Medical Device Testing Product Portfolio
- 7.4.5 Eurofins Recent Developments
- 7.5 RCTS
- 7.5.1 RCTS Company Information
- 7.5.2 RCTS Business Overview
- 7.5.3 RCTS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 RCTS Pharmaceutical and Medical Device Testing Product Portfolio
- 7.5.5 RCTS Recent Developments
- 7.6 Nelson Laboratories
- 7.6.1 Nelson Laboratories Company Information
- 7.6.2 Nelson Laboratories Business Overview
- 7.6.3 Nelson Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Nelson Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 7.6.5 Nelson Laboratories Recent Developments
- 7.7 DeviceLab
- 7.7.1 DeviceLab Company Information
- 7.7.2 DeviceLab Business Overview
- 7.7.3 DeviceLab Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 DeviceLab Pharmaceutical and Medical Device Testing Product Portfolio
- 7.7.5 DeviceLab Recent Developments
- 7.8 EAG Laboratories
- 7.8.1 EAG Laboratories Company Information
- 7.8.2 EAG Laboratories Business Overview
- 7.8.3 EAG Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 EAG Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 7.8.5 EAG Laboratories Recent Developments
- 7.9 EdgeOne Medical
- 7.9.1 EdgeOne Medical Company Information
- 7.9.2 EdgeOne Medical Business Overview
- 7.9.3 EdgeOne Medical Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 EdgeOne Medical Pharmaceutical and Medical Device Testing Product Portfolio
- 7.9.5 EdgeOne Medical Recent Developments
- 7.10 Element
- 7.10.1 Element Company Information
- 7.10.2 Element Business Overview
- 7.10.3 Element Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Element Pharmaceutical and Medical Device Testing Product Portfolio
- 7.10.5 Element Recent Developments
- 7.11 NAMSA
- 7.11.1 NAMSA Company Information
- 7.11.2 NAMSA Business Overview
- 7.11.3 NAMSA Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 NAMSA Pharmaceutical and Medical Device Testing Product Portfolio
- 7.11.5 NAMSA Recent Developments
- 7.12 Pace Labs
- 7.12.1 Pace Labs Company Information
- 7.12.2 Pace Labs Business Overview
- 7.12.3 Pace Labs Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 Pace Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 7.12.5 Pace Labs Recent Developments
- 7.13 Intertek
- 7.13.1 Intertek Company Information
- 7.13.2 Intertek Business Overview
- 7.13.3 Intertek Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.13.4 Intertek Pharmaceutical and Medical Device Testing Product Portfolio
- 7.13.5 Intertek Recent Developments
- 7.14 Associates of Cape Cod (ACC)
- 7.14.1 Associates of Cape Cod (ACC) Company Information
- 7.14.2 Associates of Cape Cod (ACC) Business Overview
- 7.14.3 Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.14.4 Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Product Portfolio
- 7.14.5 Associates of Cape Cod (ACC) Recent Developments
- 7.15 Tentamus
- 7.15.1 Tentamus Company Information
- 7.15.2 Tentamus Business Overview
- 7.15.3 Tentamus Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.15.4 Tentamus Pharmaceutical and Medical Device Testing Product Portfolio
- 7.15.5 Tentamus Recent Developments
- 7.16 EKG Labs
- 7.16.1 EKG Labs Company Information
- 7.16.2 EKG Labs Business Overview
- 7.16.3 EKG Labs Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.16.4 EKG Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 7.16.5 EKG Labs Recent Developments
- 7.17 MycoScience
- 7.17.1 MycoScience Company Information
- 7.17.2 MycoScience Business Overview
- 7.17.3 MycoScience Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.17.4 MycoScience Pharmaceutical and Medical Device Testing Product Portfolio
- 7.17.5 MycoScience Recent Developments
- 7.18 GDMDT
- 7.18.1 GDMDT Company Information
- 7.18.2 GDMDT Business Overview
- 7.18.3 GDMDT Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.18.4 GDMDT Pharmaceutical and Medical Device Testing Product Portfolio
- 7.18.5 GDMDT Recent Developments
- 7.19 Guangdong Lewwin
- 7.19.1 Guangdong Lewwin Company Information
- 7.19.2 Guangdong Lewwin Business Overview
- 7.19.3 Guangdong Lewwin Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.19.4 Guangdong Lewwin Pharmaceutical and Medical Device Testing Product Portfolio
- 7.19.5 Guangdong Lewwin Recent Developments
- 7.20 GTTC
- 7.20.1 GTTC Company Information
- 7.20.2 GTTC Business Overview
- 7.20.3 GTTC Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.20.4 GTTC Pharmaceutical and Medical Device Testing Product Portfolio
- 7.20.5 GTTC Recent Developments
- 7.21 PONY
- 7.21.1 PONY Company Information
- 7.21.2 PONY Business Overview
- 7.21.3 PONY Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.21.4 PONY Pharmaceutical and Medical Device Testing Product Portfolio
- 7.21.5 PONY Recent Developments
- 7.22 Guangzhou Guobiao
- 7.22.1 Guangzhou Guobiao Company Information
- 7.22.2 Guangzhou Guobiao Business Overview
- 7.22.3 Guangzhou Guobiao Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.22.4 Guangzhou Guobiao Pharmaceutical and Medical Device Testing Product Portfolio
- 7.22.5 Guangzhou Guobiao Recent Developments
- 7.23 CAS Testing Technical Services
- 7.23.1 CAS Testing Technical Services Company Information
- 7.23.2 CAS Testing Technical Services Business Overview
- 7.23.3 CAS Testing Technical Services Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.23.4 CAS Testing Technical Services Pharmaceutical and Medical Device Testing Product Portfolio
- 7.23.5 CAS Testing Technical Services Recent Developments
- 7.24 Guangzhou General Pharmaceutical Research Institute
- 7.24.1 Guangzhou General Pharmaceutical Research Institute Company Information
- 7.24.2 Guangzhou General Pharmaceutical Research Institute Business Overview
- 7.24.3 Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.24.4 Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Product Portfolio
- 7.24.5 Guangzhou General Pharmaceutical Research Institute Recent Developments
- 7.25 Guangdong Huawei Testing
- 7.25.1 Guangdong Huawei Testing Company Information
- 7.25.2 Guangdong Huawei Testing Business Overview
- 7.25.3 Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.25.4 Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Product Portfolio
- 7.25.5 Guangdong Huawei Testing Recent Developments
- 7.26 Shanghai Ingeer
- 7.26.1 Shanghai Ingeer Company Information
- 7.26.2 Shanghai Ingeer Business Overview
- 7.26.3 Shanghai Ingeer Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.26.4 Shanghai Ingeer Pharmaceutical and Medical Device Testing Product Portfolio
- 7.26.5 Shanghai Ingeer Recent Developments
- 7.27 CIRS
- 7.27.1 CIRS Company Information
- 7.27.2 CIRS Business Overview
- 7.27.3 CIRS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.27.4 CIRS Pharmaceutical and Medical Device Testing Product Portfolio
- 7.27.5 CIRS Recent Developments
- 7.28 Shanghai Fuda
- 7.28.1 Shanghai Fuda Company Information
- 7.28.2 Shanghai Fuda Business Overview
- 7.28.3 Shanghai Fuda Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.28.4 Shanghai Fuda Pharmaceutical and Medical Device Testing Product Portfolio
- 7.28.5 Shanghai Fuda Recent Developments
8 North America
- 8.1 North America Pharmaceutical and Medical Device Testing Revenue (2021-2032)
- 8.2 North America Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 8.2.1 North America Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026)
- 8.2.2 North America Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032)
- 8.3 North America Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
- 8.4 North America Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 8.4.1 North America Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026)
- 8.4.2 North America Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032)
- 8.5 North America Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
- 8.6 North America Pharmaceutical and Medical Device Testing Revenue by Country
- 8.6.1 North America Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026)
- 8.6.3 North America Pharmaceutical and Medical Device Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pharmaceutical and Medical Device Testing Revenue (2021-2032)
- 9.2 Europe Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032)
- 9.3 Europe Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032)
- 9.5 Europe Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Pharmaceutical and Medical Device Testing Revenue by Country
- 9.6.1 Europe Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Pharmaceutical and Medical Device Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pharmaceutical and Medical Device Testing Revenue (2021-2032)
- 10.2 China Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 10.2.1 China Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026)
- 10.2.2 China Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032)
- 10.3 China Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
- 10.4 China Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 10.4.1 China Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026)
- 10.4.2 China Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032)
- 10.5 China Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharmaceutical and Medical Device Testing Revenue (2021-2032)
- 11.2 Asia Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032)
- 11.3 Asia Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032)
- 11.5 Asia Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Pharmaceutical and Medical Device Testing Revenue by Country
- 11.6.1 Asia Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Pharmaceutical and Medical Device Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharmaceutical and Medical Device Testing Revenue (2021-2032)
- 12.2 SAMEA Pharmaceutical and Medical Device Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pharmaceutical and Medical Device Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pharmaceutical and Medical Device Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Pharmaceutical and Medical Device Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pharmaceutical and Medical Device Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pharmaceutical and Medical Device Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pharmaceutical and Medical Device Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Pharmaceutical and Medical Device Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pharmaceutical and Medical Device Testing Revenue by Country
- 12.6.1 SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pharmaceutical and Medical Device Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst